Consumer Discretionary: XLY
In yesterday's post, we discussed the issue associated with Apple Inc. Mobile phones are a necessity in today's world. One needs to be connected to stay involved with work and…
Is it time to fade Apple Inc?: AAPL
Apple Inc. needs no introduction. The iconic maker of the iPhone and Macintosh computers are used by hundreds of millions of people. Its success has been so spectacular that it…
De-Risk Further, Boeing Crashes Again & Watch the Euro
We do not like how stocks are trading early in this calendar year. As a result, traders should reduce their long exposure in the equity market. This article is for…
Home Depot: HD
Most experienced investors are waiting for the wheels to fall off the real estate market. To their surprise, home, condominium, and apartment prices have been far more resilient against rising…
Micron Technologies: MU
The world of professional investors and the financial media are star-struck by the idea of artificial intelligence. They do not know how to profit from it but know that computational…
Close a few trades & Sell Cathy’s ARKK
In the October to November time frame, we turned bullish as we looked for a Santa Claus rally going into the Christmas season. We thought stocks would peak sometime between…
Equity Review 2023
The equity market frustrated the bulls and the bears for the year's first nine months. This article is for registered members - please login or click here to subscribe or register for…
Charter Communications: CHTR
There is a lot of talk about "cord-cutting" in the media world. Much of this is justified. Young people do not sign up for the full cable services bundle of…
A Time to Hedge?: SPY
Over the last four months or so, we have found a bunch of undervalued stocks. This caused our overall posture to swing from bearish to bullish by default. Fortunately for…
SPDR S&P Biotech ETF: XBI
The Biotech industry has produced therapies that have cured humans of serious diseases. One of our favorite companies in this space is Bipgen (BIIB). They provided us with a cure…